semaglutide long acting (AdoGel Sema) / Adocia - LARVOL DELTA

Fourth quarter 2024 Highlights (Businesswire) - "AdoGel's unique technology could enable monthly or even quarterly injections. New preclinical results have been selected for a poster presentation at the ATTD 2025 conference (18th International Conference on Advanced Technologies & Treatments for Diabetes, 19-22 March, 2025, Amsterdam, The Netherlands) and for an oral presentation at the SFD 2025 congress (Congress of the Société Francophone du Diabète, April 1-4, 2025, Paris, France)."

Preclinical • Diabetes